Number of the records: 1
neostigmín
SYS d009388 LBL 00000nz--a2200000o--4500 005 20250606213031.0 008 990101|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 $d BA006 065 $a D02.092.877.674.666 065 $a D02.675.276.602 066 $a 01 $c 03 150 $a neostigmín $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 450 $w v $a Synstigmin $2 eng 550 $7 sllk_us_auth*d002800 $Y Cholinesterase Inhibitors $w P $a inhibítory cholínesteráz 550 $7 sllk_us_auth*d010277 $Y Parasympathomimetics $w P $a parasympatomimetiká 680 9-
$i A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier. $2 eng 750 -2
$a Neostigmine $2 eng 980 $x M
Number of the records: 1